Clinical trial
Randomised Phase III Trial of Chemoradiotherapy With or Without Paclitaxel in Patients With Squamous-cell Anal Cancer
NCT02526953 is registered in ClinicalTrials.gov with Blokhin's Russian Cancer Research Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Phase III Trial of Chemoradiotherapy With or Without Paclitaxel in Patients With Squamous-cell Anal Cancer
- Lead sponsor
- Blokhin's Russian Cancer Research Center
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- January 31, 2016
- Completion date
- October 31, 2022
- Enrollment
- 314 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.